• Halozyme Therapeutics (NASDAQ:HALO) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS

    Source: Buzz FX / 19 Feb 2025 20:46:11   America/New_York


    Halozyme Therapeutics (NASDAQ:HALO) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Halozyme Therapeutics ( NASDAQ:HALO - Get Free Report ) issued its q
    Read more...
Share on,